Work With Data
Profile
user

Eisai in the news

Updated: 37d ago

Analyze the latest Eisai news, with a current neutral sentiment polarity (-0.02) or the entire set.

Latest news

Here are the latest news on this scope:

Biogen, Eisai to shift some Alzheimer's drug production to US

Read on: Nikkei link
37d ago

Biogen partner Eisai cut US jobs. Now can it boost Alzheimer's drug sales?

Read on: Nikkei link
47d ago

Eisai eyes fiscal 2025 U.S. approval for home version of Alzheimer's drug

Read on: Nikkei link
149d ago

Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says

Read on: CNBC News link
318d ago

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

Read on: CNBC News link
326d ago

Japan's Eisai aims for 2030 U.S. release of new Alzheimer's drug

Read on: Nikkei link
355d ago

Eisai to offer Alzheimer's drug in China from July

Read on: Nikkei link
401d ago

Eisai seeks expanded use of Alzheimer's drug for prevention

Read on: Nikkei link
546d ago

Extract data

Extract all the news on this scope:

Visualize data

Here are some available charts on these news:

Evolution through time

Distribution of sources in the news

Distribution of sections in the news

Sentiment polarity through time